4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-054606
Chairman and CEO bought 4,500 shares at an average $0.88 ($3,970)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-10-09 | Purchase | +500 | $0.98 | $490 | 10,703,746 | D |
| Niihara Yutaka Chairman and CEO | 2020-10-12 | Purchase | +1,000 | $0.90 | $900 | 10,704,746 | D |
| Niihara Yutaka Chairman and CEO | 2020-10-13 | Purchase | +3,000 | $0.86 | $2,580 | 10,707,746 | D |
| Open-market purchases · 4,500 sh · avg $0.88 · $3,970 | |||||||
Loading xslF345X03/doc4.xml…